Kerri L. Rossi

Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)

Ronald N. Jones, M. Rybak, Steven N. Leonard, 2008, Journal of Clinical Microbiology.

Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model

G. Kaatz, M. Rybak, Steven N. Leonard, 2008, Antimicrobial Agents and Chemotherapy.

Synthesis and antibacterial properties of (-)-nor-platencin.

M. Rybak, B. Snider, Kerri L. Rossi, 2009, Organic letters.

Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007)

Ronald N. Jones, M. Rybak, Steven N. Leonard, 2008, Journal of Clinical Microbiology.

Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.

M. Rybak, Steven N. Leonard, K. L. Newton, 2009, The Journal of antimicrobial chemotherapy.

Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.

Ronald N. Jones, M. Rybak, H. Sader, 2009, The Journal of antimicrobial chemotherapy.